dapagliflozin - Generic mfg.
Entresto (sacubitril/valsartan) - Novartis, ROVI Pharmaceuticals Laboratories
Therapeutic Effects of Sacubitril/Valsartan and Dapagliflozin on Oxidative Stress and Iron Dysregulation in Monocrotaline-Induced Pulmonary Arterial Hypertension (AHA 2026) - Oct 8, 2026 - Abstract #MDP2401; Pres time: Nov 9, 2026; 11:20 AM - 11:25 AM; Location: Moderated Digital Poster 6‚ Clinical Science Zone 1; In-Person; No abstract available 
Oxidative stress • Cardiovascular • Pulmonary Arterial Hypertension • Respiratory Diseases
https://eppro01.ativ.me/web/page.php?page=session&project=AHA26&id=P9494
 
Chin-Chang Cheng; PEI-LING CHI; Cheng-Hung Chiang; Wei-Chun Huang; Hong-Chou Yang
 
Oct 8, 2026
 
Prev Next